MedTrace Logo

Effect of Oligofructose on Appetite in Overweight Subjects

NCT00912197 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2021-01-14

Study results available
· View outcomes & findings →

Summary

This study seeks to look into the effects of oligofructose supplementation on appetite, energy intake, and body weight and body composition in overweight subjects. Compared to a placebo product (cellulose) oligofructose is hypothesised to suppress hunger and thereby reduce food intake moderately leading to a decrease in body weight.

Conditions

Interventions

DIETARY_SUPPLEMENT

Oligofructose

Participants will be asked to consume 30g of oligofructose daily for six weeks after a 2-week run-in.

DIETARY_SUPPLEMENT

Placebo

Participants will be asked to consume 3 doses (a total of 30g dietary fibres) of the placebo product daily for six weeks after a 2-week run-in

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Gary S Frost · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00912197 on ClinicalTrials.gov